))
S3 E4 – “No ‘One Type Fits All’ in Lung Cancer Treatment”: An Interview with Dr Anne-Marie Baird (Lung Cancer Europe)
Manage episode 407172572 series 3558520
Innhold levert av Karger Publishers. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Karger Publishers eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
For this episode of Karger’s The Waiting Room Podcast, we spoke again with Dr Anne-Marie Baird, who currently serves as the president of Lung Cancer Europe (LuCE). She is a Senior Research Fellow at Trinity College Dublin, Ireland, and a patient advocate. In this episode we are going to focus on non-small cell lung cancer, genetic predisposition, biomarkers and treatment.
More information on lung cancer is freely available here:
- Fast Facts for Patients: Non-small Cell Lung Cancer with KRAS Mutation
- Infographic Summary Sheets for Patients:
KRAS G12C in Metastatic Non-Small Cell Lung Cancer
When Checkpoint Inhibitor Therapy Stops Working
Biomarkers in Metastatic Non-Small Cell Lung Cancer
For more podcast episodes from Karger please visit https://www.karger.com/pages/podcasts.
41 episoder
Del
